Title : Prognostic impact of the TP53 rs1625895 polymorphism in DLBCL patients.

Pub. Date : 2015 Apr

PMID : 25430047






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 This study aimed to clarify the association between the TP53 rs1625895 polymorphism and the efficiency of R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, prednisolone) therapy in 106 patients with diffuse large B cell lymphoma (DLBCL). Cyclophosphamide DNA damage inducible transcript 3 Homo sapiens